140 related articles for article (PubMed ID: 23337245)
1. Determination of lamivudine and zidovudine permeability using a different ex vivo method in Franz cells.
Dezani AB; Pereira TM; Caffaro AM; Reis JM; Serra CH
J Pharmacol Toxicol Methods; 2013; 67(3):194-202. PubMed ID: 23337245
[TBL] [Abstract][Full Text] [Related]
2. Intestinal permeability of lamivudine (3TC) and two novel 3TC prodrugs. Experimental and theoretical analyses.
Gualdesi MS; Briñón MC; Quevedo MA
Eur J Pharm Sci; 2012 Dec; 47(5):965-78. PubMed ID: 23072916
[TBL] [Abstract][Full Text] [Related]
3. Lamivudine permeability study: a comparison between PAMPA, ex vivo and in situ Single-Pass Intestinal Perfusion (SPIP) in rat jejunum.
Reis JM; Dezani AB; Pereira TM; Avdeef A; Serra CH
Eur J Pharm Sci; 2013 Mar; 48(4-5):781-9. PubMed ID: 23298578
[TBL] [Abstract][Full Text] [Related]
4. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein limits the absorption of the anti-HIV drug zidovudine through rat intestinal segments.
Quevedo MA; Nieto LE; Briñón MC
Eur J Pharm Sci; 2011 Jun; 43(3):151-9. PubMed ID: 21540109
[TBL] [Abstract][Full Text] [Related]
6. Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier.
Kuo YC; Chen HH
Int J Pharm; 2006 Dec; 327(1-2):160-9. PubMed ID: 16939704
[TBL] [Abstract][Full Text] [Related]
7. Standardization of an ex vivo method for determination of intestinal permeability of drugs using everted rat intestine apparatus.
Dixit P; Jain DK; Dumbwani J
J Pharmacol Toxicol Methods; 2012 Jan; 65(1):13-7. PubMed ID: 22107724
[TBL] [Abstract][Full Text] [Related]
8. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
[TBL] [Abstract][Full Text] [Related]
9. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
[TBL] [Abstract][Full Text] [Related]
10. A rapid and sensitive method for simultaneous determination of lamivudine and zidovudine in human serum by on-line solid-phase extraction coupled to liquid chromatography/tandem mass spectrometry detection.
Estrela Rde C; Salvadori MC; Suarez-Kurtz G
Rapid Commun Mass Spectrom; 2004; 18(10):1147-55. PubMed ID: 15150840
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK-MDR1, and Caco-2 cell monolayers.
de Souza J; Benet LZ; Huang Y; Storpirtis S
J Pharm Sci; 2009 Nov; 98(11):4413-9. PubMed ID: 19472342
[TBL] [Abstract][Full Text] [Related]
12. In vitro-in vivo Pharmacokinetic correlation model for quality assurance of antiretroviral drugs.
Rojas Gómez R; Restrepo Valencia P
Colomb Med (Cali); 2015 Sep; 46(3):109-16. PubMed ID: 26600625
[TBL] [Abstract][Full Text] [Related]
13. Development of fixed dose combination tablets containing zidovudine and lamivudine for paediatric applications.
Kayitare E; Vervaet C; Ntawukulilyayo JD; Seminega B; Bortel V; Remon JP
Int J Pharm; 2009 Mar; 370(1-2):41-6. PubMed ID: 19059324
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic Artificial Membrane Permeability Assay over Franz Cell Apparatus Using BCS Model Drugs.
de Souza Teixeira L; Vila Chagas T; Alonso A; Gonzalez-Alvarez I; Bermejo M; Polli J; Rezende KR
Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33086670
[TBL] [Abstract][Full Text] [Related]
15. [Modulation on the P-glycoprotein in the jejunum by combined use of Glycyrrhiza inflata and Kansui].
Sun YB; Li GF; Tang ZK; Wu BY
Yao Xue Xue Bao; 2010 Apr; 45(4):510-6. PubMed ID: 21355220
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two approaches of intestinal absorption by puerarin.
Li H; Dong L; Liu Y; Wang G; Zhang L; Qiao Y
J Pharmacol Toxicol Methods; 2014; 70(1):6-11. PubMed ID: 24674709
[TBL] [Abstract][Full Text] [Related]
17. The utility of rat jejunal permeability for biopharmaceutics classification system.
Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Islambulchilar Z
Drug Dev Ind Pharm; 2009 Dec; 35(12):1496-502. PubMed ID: 19929209
[TBL] [Abstract][Full Text] [Related]
18. Regional Intestinal Permeability in Rats: A Comparison of Methods.
Roos C; Dahlgren D; Sjögren E; Tannergren C; Abrahamsson B; Lennernäs H
Mol Pharm; 2017 Dec; 14(12):4252-4261. PubMed ID: 28920690
[TBL] [Abstract][Full Text] [Related]
19. In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation.
Franek F; Jarlfors A; Larsen F; Holm P; Steffansen B
Eur J Pharm Sci; 2015 Sep; 77():303-13. PubMed ID: 26091569
[TBL] [Abstract][Full Text] [Related]
20. Frog intestinal sac: a new in vitro method for the assessment of intestinal permeability.
Trapani G; Franco M; Trapani A; Lopedota A; Latrofa A; Gallucci E; Micelli S; Liso G
J Pharm Sci; 2004 Dec; 93(12):2909-19. PubMed ID: 15459890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
